Share
Services
The sale of the Austrian project business and spa operations of VAMED Vitality World to PORR, announced by Fresenius in October 2025, has received the necessary approvals and will be completed on December 31, 2025.
December 15, 2025 - 01:00 pm CET
Virtual
Members of the Fresenius and Fresenius Kabi management team provided insights into the Biopharma segment.
Please use the link below to watch the replay of the webcast.
The virtual Biopharma ‘Meet the Management’ event took place on December 15, 2025 at 01:00 pm CET.
Members of the Fresenius and Fresenius Kabi management team provided insights into the Biopharma segment.
Please use the link below to watch the replay of the webcast.
Our Fresenius Capital Markets Day 2024 took place on June 5, 2024 in London.
During the event, we presented and discussed Fresenius Helios’ role as Operating Company within #FutureFresenius, elaborated on its strategy in more detail and provided in-depth information on Fresenius Helios’ operating businesses and growth prospects.
Presenters were Michael Sen, CEO of Fresenius, and Robert Möller, CEO of Fresenius Helios, and his management team.
A recording of the Capital Markets Day is available below in various languages.
The Fresenius Capital Markets Day took place in London on May 25, 2023, in a hybrid format. A replay of the webcast is available.
As part of the event, we presented and discussed Fresenius Kabi’s role as Operating Company within #FutureFresenius, elaborated on its “Vision 2026” in more detail and provided in-depth information on the company’s operating businesses and growth prospects.
Presenters were Michael Sen, CEO of Fresenius, and Pierluigi Antonelli, CEO of Fresenius Kabi, and his management team.
Contact
Senior Vice President Investor Relations
Head of Investor Relations
T: +49 (0) 6172 608-97033
nick.stone@fresenius.com
Biopharma ‚Meet the Management‘ Presentation
January 19, 2026
Frankfurt, Germany
January 19 – 20, 2026
January 12, 2026
San Francisco, USA
January 12 – 14, 2026
